...
首页> 外文期刊>Cell cycle >Absence of germline mutations in genes within the MAP kinase pathway in familial non-medullary thyroid cancer.
【24h】

Absence of germline mutations in genes within the MAP kinase pathway in familial non-medullary thyroid cancer.

机译:家族性非髓样甲状腺癌的MAP激酶途径内基因的种系突变缺失。

获取原文
获取原文并翻译 | 示例

摘要

Follicular cell-originated non-medullary thyroid cancer (NMTC) is the most common thyroid cancer, accounting for more than 90% of all thyroid malignancies.There is a widely recognized distinct familial form of NMTC (FNMTC) which is characterized by the occurrence of this cancer in two or more first-degree family members, widi a tendency to have multifocality, early onset, increased recurrence, and higher degree of aggressiveness. FNMTC accounts for approximately 5% of non-medullary thyroid cancers. Histologically, 90% of FNMTC are papillary thyroid cancer (PTC) and the remainder is follicular thyroid cancer (FTC), including Hurthle-cell variant. Linkage analysis on kindreds from different families with FNMTC mapped the susceptible locus to several chromosomes, but no specific susceptible gene has been identified.
机译:滤泡细胞源性非髓样甲状腺癌(NMTC)是最常见的甲状腺癌,占所有甲状腺恶性肿瘤的90%以上.NMTC(FNMTC)是一种广泛公认的独特家族形式,其特征是在两个或多个一级家庭成员中患有这种癌症,倾向于多灶性,早发,复发增加和侵略性较高。 FNMTC约占非甲状腺甲状腺癌的5%。从组织学上讲,FNMTC的90%为甲状腺乳头状癌(PTC),其余为滤泡性甲状腺癌(FTC),包括Hurthle细胞变异。对来自不同家族的具有FNMTC的亲属进行的连锁分析将易感基因座映射到了多个染色体,但尚未鉴定出特异性易感基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号